Recursion Pharmaceuticals ( (RXRX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Recursion Pharmaceuticals’ stock is experiencing a notable upward movement due to a surge in call options trading, which has reached six times the usual volume. This increase is fueled by rising implied volatility, indicating growing investor interest ahead of the company’s earnings report on August 7. The low Put/Call Ratio of 0.16 highlights a strong preference for call options, showcasing optimism about the company’s future. Additionally, recent news of a strategic acquisition has further boosted positive sentiment around the stock.
More about Recursion Pharmaceuticals
YTD Price Performance: -23.44%
Average Trading Volume: 25,540,330
Technical Sentiment Signal: Sell
Current Market Cap: $2.33B
For further insights into RXRX stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.